| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 01/10/2008 | US20080009434 at least one aromatic amino acid (phenylalanine); hollow and fibrillar peptide; macroscopic and microscopic articles; self-assembled; 9-fluorenylmethyloxycarbonyl (Fmoc) and benzyloxycarbonyl (Cbz); slow release of drug, nucleic acid molecule or a polypeptide; antibody |
| 01/10/2008 | US20080009433 Use of glp-1 or analogs in treatment of myocardial infarction |
| 01/10/2008 | US20080009076 Methods of identifying compounds that modulate il-4 receptor-mediated ige synthesis utilizing a thioredoxin-like 32 kda protein |
| 01/10/2008 | US20080009056 Polypeptide, cDNA encoding the same and use of them |
| 01/10/2008 | US20080009025 Protein kinase regulation |
| 01/10/2008 | US20080009022 Immunization of dairy cattle with chimeric gapC protein against streptococcus infection |
| 01/10/2008 | US20080009014 Receptor activator of NF-kappaB |
| 01/10/2008 | US20080009008 Composition and method for treating lupus nephritis |
| 01/10/2008 | US20080009004 Claudin polypeptides, polynucleotides, and methods of making and use thereof |
| 01/10/2008 | US20080008764 Carbon-substituted diketopiperazine delivery systems |
| 01/10/2008 | US20080008760 Functionalized carbon nanotubes, a process for preparing the same and their use in medicinal chemistry |
| 01/10/2008 | US20080008758 Granulate-matrix |
| 01/10/2008 | US20080008736 Random copolymers of methacrylates and acrylates |
| 01/10/2008 | US20080008733 Controlled release compositions for interferon based on pegt/pbt block copolymers |
| 01/10/2008 | US20080008717 Polynucleotide Fragments of an Infectious Human Endogenous Retrovirus |
| 01/10/2008 | US20080008715 antibodies which recognizes membrane glycoprotein (ULBP) for use in treatment and prevention of cell proliferative disorders; immunotherapy |
| 01/10/2008 | US20080008714 TWEAK receptor agonists as anti-angiogenic agents |
| 01/10/2008 | US20080008712 Novel Phosphorylated Sequences of the Phosphatase Cdc25B, Antibodies for Said Sequences and Use Thereof |
| 01/10/2008 | US20080008706 B7S1: an immune modulator |
| 01/10/2008 | US20080008701 C-met receptor regulation by angiotensin iv (at4) receptor ligands |
| 01/10/2008 | US20080008698 Non-Surgical Method for Preventing or Reducing the Rate of the Progression of Non-Proliferative Diabetic Retinopathy and the Treatment of Other Ocular Conditions |
| 01/10/2008 | US20080008697 Polynucleotides encoding novel PCSK9 variants |
| 01/10/2008 | US20080008696 Markers for differential diagnosis and methods of use thereof |
| 01/10/2008 | US20080008695 Compositions of prokaryotic phenylalanine ammonia-lyase and methods of using compositions thereof |
| 01/10/2008 | US20080008694 Methods to prevent and treat diseases |
| 01/10/2008 | US20080008691 Modified growth hormone |
| 01/10/2008 | US20080008689 Method for Transdifferentiation of Non Pancreatic Stem Cells to the Pancreatic Differentiation Pathway |
| 01/10/2008 | US20080008688 System and Method for Genetically Treating Cardiac Conduction Disturbances |
| 01/10/2008 | US20080008687 Transposon-Based Targeting System |
| 01/10/2008 | US20080008683 Polypeptide Sequence Involved in the Modulation of the Immunosuppresive Effect of Viral Proteins |
| 01/10/2008 | US20080008682 Agonists; Treatment of Hepatitis C virus; combination with other drugs; phosphonate derivatives of purine or thiazolo(4,5-d)pyrimidine rings |
| 01/10/2008 | US20080008681 Macrocyclic hepatitis c virus serine protease inhibitors |
| 01/10/2008 | US20080008680 pure mutant Interleukin-15 polypeptide; immunosuppressant; immunotherapy |
| 01/10/2008 | US20080008662 Aerosol Drug Inhibition of Lung Cancer |
| 01/10/2008 | US20080008661 Methods and compositions for treating erectile dysfunction |
| 01/10/2008 | US20080008650 Endometriosis cell targeting peptide and uses thereof |
| 01/10/2008 | DE19933492B4 Konjugat zur Vermittlung eines zell-, kompartiment- oder membranspezifischen Transports von Wirksubstanzen, Verfahren zu dessen Herstellung und dessen Verwendung A conjugate for placement of a cell, or membrane compartment-specific transport of active substances, a process for its preparation and its use |
| 01/10/2008 | DE10109466B4 Verfahren und Mittel zur Modifikation humaner Angiogenese Method and means for modification of human angiogenesis |
| 01/10/2008 | DE10015463B4 Creme in Form einer überwässerten Wasser-in-Öl-Emulsion Cream in the form of a überwässerten water-in-oil emulsion |
| 01/10/2008 | CA2664399A1 Use of hypothermia inducing drugs |
| 01/10/2008 | CA2658060A1 Erythropoietin-producing organoid precursor, production method thereof, and method for treating erythropoietin-related disorder |
| 01/10/2008 | CA2656989A1 Methods to prevent and treat diseases |
| 01/10/2008 | CA2656959A1 Prophylactic or therapeutic agent for viral disease |
| 01/10/2008 | CA2656757A1 Novel anologs of vasoactive intestinal peptide |
| 01/10/2008 | CA2656278A1 Compositions and methods for treating rotator cuff injuries |
| 01/10/2008 | CA2656135A1 Human il-4 muteins in cancer therapy |
| 01/10/2008 | CA2655923A1 Glucagon-like peptides and uses thereof |
| 01/10/2008 | CA2655029A1 Compounds and combinations thereof for inhibiting beta-amyloid production and methods of use thereof |
| 01/10/2008 | CA2650478A1 Compositions comprising a dissociated glucocorticoid receptor agonist and an immunosuppressive agent for treating dry eye |
| 01/09/2008 | EP1876241A2 Compositions and methods for the treatment and diagnosis of breast cancer |
| 01/09/2008 | EP1876238A1 Novel polypeptide and use thereof |
| 01/09/2008 | EP1876184A1 A method for isolating and purifying immuno-modulating polypeptide from cow placenta |
| 01/09/2008 | EP1876183A1 Minimized small peptides with high affinity for factor VIII and factor VIII-like proteins |
| 01/09/2008 | EP1876173A1 Chiral intermediates for the preparation of peptidomimetic protease inhibitors |
| 01/09/2008 | EP1876169A1 Phenyl-containing n-acyl amine and aminoacid derivatives, methods for the production thereof, a pharmaceutical composition and the use thereof |
| 01/09/2008 | EP1875924A2 RGD-enriched gelatine-like proteins with enhanced cell binding |
| 01/09/2008 | EP1875923A2 Use of fractalkine for the production of a neuroprotector drug against cell death |
| 01/09/2008 | EP1875922A2 Intestinal trefoil proteins |
| 01/09/2008 | EP1875921A1 Dpp4 inhibitor and pharmaceutical application thereof |
| 01/09/2008 | EP1875909A2 Use of antagonists of PYY receptors for treating irritable bowel syndrome |
| 01/09/2008 | EP1875900A2 JAK/STAT pathway inhibitors and the use thereof for the treatment of osteoarthritis |
| 01/09/2008 | EP1875816A2 Beverages with specialized supplements |
| 01/09/2008 | EP1875247A2 Selective modulation of tumour necrosis factor receptors in therapy |
| 01/09/2008 | EP1875244A2 Proliferation of muc1 expressing cells |
| 01/09/2008 | EP1874931A1 Micro rna |
| 01/09/2008 | EP1874824A2 Methods for generating stably linked complexes composed of homodimers, homotetramers or dimers of dimers and uses |
| 01/09/2008 | EP1874813A2 Trimeric peptides for use in treating obesity |
| 01/09/2008 | EP1874807A2 Fusion proteins comprising a non-cytotoxic protease, a targeting moiety, a protease cleavage site and a translocation domain |
| 01/09/2008 | EP1874804A2 Lawsonia protein useful as a component in subunit vaccine and methods of making and using thereof |
| 01/09/2008 | EP1874803A2 Carrier for targeting nerve cells |
| 01/09/2008 | EP1874800A1 Diagnostic and therapeutic agents |
| 01/09/2008 | EP1874796A2 Compositions and methods for treating or preventing overweight or obesity with zinc-charged protein fragments |
| 01/09/2008 | EP1874358A2 Improved stably tethered structures of defined compositions with multiple functions or binding specificities |
| 01/09/2008 | EP1874342A2 Compositions and methods for cancer immunotherapy |
| 01/09/2008 | EP1874341A1 Erythrocytes containing arginine deiminase |
| 01/09/2008 | EP1874340A2 Elastin protective polyphenolics and methods of using the same |
| 01/09/2008 | EP1874339A1 Pharmaceutical preparations of a glp-1 molecule and an anti-emetic drug |
| 01/09/2008 | EP1874338A2 Novel use |
| 01/09/2008 | EP1874337A2 Compositions and uses of a galectin for treatment of dry eye syndrome |
| 01/09/2008 | EP1874336A2 Method of improving learning and memory in mammals |
| 01/09/2008 | EP1874335A2 Methods for magnetic resonance imaging |
| 01/09/2008 | EP1874334A2 Compositions containing beta 2-glycoprotein i-derived peptides for the prevention and/or treatment of vascular disease |
| 01/09/2008 | EP1874333A2 Mannan-binding lectin (mbl) in the treatment of immunocompromised conditions asssociated with cancer |
| 01/09/2008 | EP1874332A2 Immunogenic egfr peptides comprising foreign t cell stimulating epitope |
| 01/09/2008 | EP1874331A2 Use |
| 01/09/2008 | EP1874330A2 Peptides that down regulate the activity of plasma membrane transporters including sodium-d-glucose cotransporter sglt1 |
| 01/09/2008 | EP1874329A1 Blood pressure lowering protein hydrolysates |
| 01/09/2008 | EP1874328A1 Use of a peptide in the form of a slimming active principle |
| 01/09/2008 | EP1874327A1 Antiviral peptides |
| 01/09/2008 | EP1874297A1 Method of treating multiple myeloma using 17-aag or 17-ag or a prodrug of either in combination with a proteasome inhibitor |
| 01/09/2008 | EP1874281A2 Optimizing pharmacodynamics of therapeutic agents for treating vascular tissue |
| 01/09/2008 | EP1874270A2 Pharmaceutical aerosol composition |
| 01/09/2008 | EP1874265A2 Methods for generating new hair follicles, treating baldness, and hair removal |
| 01/09/2008 | EP1874140A1 Peptides having a health benefit and compositions comprising them |
| 01/09/2008 | EP1874129A1 Peptides having an ace inhibiting effect |
| 01/09/2008 | EP1874128A1 Peptides having an ace inhibiting effect |
| 01/09/2008 | EP1706130A4 Matrix array nanobiosensor |
| 01/09/2008 | EP1684706A4 Genes differentially expressed by acutely isolated resident progenitor cells of the human white matter |
| 01/09/2008 | EP1663262A4 Bowman-birk inhibitor compositions for treatment of muscular atrophy and degenerative muscle disease |
| 01/09/2008 | EP1610760A4 Topical l-carnitine compositions |